Neonatal, Lethal Noncompaction of the Left Ventricular Myocardium Is Allelic with Barth Syndrome  by Bleyl, Steven B. et al.
Am. J. Hum. Genet. 61:868–872, 1997
Neonatal, Lethal Noncompaction of the Left Ventricular Myocardium
Is Allelic with Barth Syndrome
Steven B. Bleyl,1 Brian R. Mumford,1 Victor Thompson,1 John C. Carey,2 Theodore J. Pysher,2,3
Thomas K. Chin,2 and Kenneth Ward1
Departments of 1Obstetrics and Gynecology, 2Pediatrics, and 3Pathology, University of Utah School of Medicine, Salt Lake City
Summary prominent trabeculations and deep intertrabecular re-
cesses within the left ventricle, characteristic of INVM.
Loss-of-function mutations in the G4.5 gene have been
Histologically, the myocardium showed loosely ar-
shown to cause Barth syndrome (BTHS), an X-linked
ranged fascicles of myocytes, especially in the subepicar-
disorder characterized by cardiac and skeletal myopa-
dial regions and more prominent in the left ventricle.
thy, short stature, and neutropenia. We recently re-
One patient survived after cardiac transplantation and
ported a family with a severe X-linked cardiomyopathy
is now age 7 years. The most recent case, now age 14
described as isolated noncompaction of the left ventricu-
mo, has survived with aggressive medical management.
lar myocardium (INVM). Other ﬁndings associated with
Originally described in a Dutch family by Barth et al.
BTHS (skeletal myopathy, neutropenia, growth retarda-
(1983), Barth syndrome (BTHS) is an X-linked recessive
tion, elevated urinary organic acids, and mitochondrial
disorder associated with dilated cardiomyopathy, skele-
abnormalities) were either absent or inconsistent. A link-
tal myopathy, neutropenia, and short stature. Addi-
age study of the X chromosome localized INVM to the
tional ﬁndings with variable expression include early
Xq28 region near the BTHS locus, suggesting that these
onset with death in infancy or early childhood, EFE,
disorders are allelic. We screened the G4.5 gene for mu-
borderline plasma carnitine deﬁciency, low muscle car-
tations in this family with SSCP and direct sequencing
nitine, elevated urinary organic acids, and myopathic
and found a novel glycine-to-arginine substitution at
facies. The early and severe presentation of cardiomyop-
position 197. This position is conserved in a homolo-
athy in the Utah kindred described in this article, as
gous Caenorhabditis elegans protein. We conclude that
well as the lack of consistent BTHS-associated ﬁndings,
INVM is a severe allelic variant of BTHS with a speciﬁc
suggested a distinct disorder of which INVM is the most
effect on the heart. This ﬁnding provides further struc-
consistent and diagnostic ﬁnding. Linkage colocaliza-
ture-function information about the G4.5 gene product
tion of INVM and BTHS to Xq28 and some phenotypic
and has implications for unexplained cases of severe
overlap between the disorders suggested that they might
infantile hypertrophic cardiomyopathy in males.
be allelic.
Subjects and MethodsIntroduction
PatientsWe recently described the clinical and pathological ﬁnd-
A complete clinical description of this family appearsings of a four generation Utah family (ﬁg. 1) in which
elsewhere (Bleyl et al., 1997). In brief, all six affectedsix males were affected with severe X-linked cardiomy-
relatives presented postnatally (birth to 7 mo) with leftopathy (Bleyl et al. 1997). Consistent ﬁndings in affected
ventricular failure and arrhythmias and with the path-males included neonatal onset of ventricular dysfunction
ognomonic echocardiographic ﬁndings of INVM. Fourfrequently complicated by arrhythmias and cardiac fail-
of the affected individuals died during infancy, one is inure within the ﬁrst year. Echocardiographic ﬁndings
cardiac failure at age 14 mo, and one is alive followingwere diagnostic of isolated noncompaction of the left
cardiac transplant at age 9 mo. The usual ﬁndings ofventricular myocardium (INVM) (Chin et al. 1990).
BTHS were either absent or inconsistent ﬁndings. Neu-Gross cardiac pathology showed dilation and hypertro-
tropenia was seen in two patients (III-2 and III-3). Mus-phy with endocardial ﬁbroelastosis (EFE) and numerous
cle weakness was seen in one patient (III-5). Neither of
two patients tested (III-5 and IV-3) had abnormal
plasma free carnatine or urinary organic acids. Abnor-Received March 26, 1997; accepted for publication July 11, 1997.
Address for correspondence and reprints: Dr. Kenneth Ward, Eccles mal mitochondria were seen in the explanted myocar-
Institute of Human Genetics, 10 North 2030 East Street, Room 2420, dium of one patient (III-5), but this was an inconsistent
Salt Lake City, UT 84112. E-mail: ken@gene1.utah.edu
ﬁnding. All hearts examined on explant or autopsy 1997 by The American Society of Human Genetics. All rights reserved.
0002-9297/97/6104-0014$02.00 showed the gross and histological ﬁndings of INVM.
868
/ 9a38$$oc09 09-09-97 12:08:15 ajhga UC-AJHG
869Bleyl et al.: INVM Is Allelic with Barth Syndrome
Figure 1 X-linked INVM pedigree. Haplotypes for STR markers shown in upper-right schematic are listed in order below each individual.
The INVM-linked haplotype is boxed.
Linkage Analysis SSCP Analysis
Blood samples were acquired after patients granted SSCP analysis was performed as follows. Radiola-
beled PCR products were diluted 1:3 in formamide load-informed consent, and DNA was extracted by standard
methods (Sambrook et al. 1989). DNA extraction from ing buffer, denatured for 5 min at 95C, and electropho-
resed in 0.61 tris-borate EDTA (TBE) buffer at 4 Wparafﬁn-embedded tissues was performed using the Ex-
Wax DNA extraction kit (Oncor). Multiplex ampliﬁca- overnight in either 1.01 Mutation Detection Enhance-
ment (MDE) polyacrylamide gel (FMC BioProducts)tion, gel electrophoresis, and genotyping of X-chromo-
some short-tandem-repeat (STR) markers was per- with 5% glycerol at room temperature or 1.01 MDE
gel at 4C. Gels were dried and exposed to ﬁlm withoutformed as described by Bleyl et al. (1995). Two-point
LOD scores were calculated using MLINK program of intensiﬁcation for 12–36 h. Mutant and control bands
from exon 8 were excised, and the DNA was eluted inthe LINKAGE package, version 5.1 (Lathrop et al.
1985), on the assumption of an X-linked recessive water for 1 h at 37C for reampliﬁcation and sequenc-
ing. The exon 8 variant was conﬁrmed using nonradiola-model, a gene frequency of .001, and a penetrance of
0.95. beled PCR ampliﬁcation and ‘‘cold SSCP’’ separation on
the Thermoﬂow system (Novex). PCR products were
Ampliﬁcation of G4.5 Exons electrophoresed in a 20% polyacrylamide TBE gel at
Primers were synthesized using the G4.5 gene se- 15C for 3.0 h in 1.251 TBE. The gel was stained with
quence in the European Molecular Biology Laboratory ethidium bromide for 30 min, and images were captured
database (X92763 and X92764) to amplify each of the using the ImageStore 7500 gel documentation system
11 exons including §10 bp of ﬂanking intron (not (Ultraviolet Products).
shown). Exon 8 was ampliﬁed using primers Ex 8A (5-
Sequence AnalysisGCTCA GGGCC CAGCT TATGC TAACA T-3) and
Ex 8B (5-GGCAG ACAGC CGAAG GTCAGCAGTC- Excised SSCP bands (two mutant and two control)
were reampliﬁed and size fractionated on a 2% Seakem3), resulting in a 152-bp product. PCR reactions con-
tained 150 ng of genomic DNA, 10 pg of each oligo, agarose (FMC Bioproducts) 11 tris-acetate EDTA gel
and puriﬁed using the GeneClean spin system (BIO 101).200 mM of each dNTP, 1.5 mM MgCl2, 10 mM Tris
pH 8.4, 40 mM NaCl2, 0.25 mM spermidine (Sigma), Puriﬁed products were sequenced using the ABI PRISM
dye terminator cycle sequencing protocol and were ana-and .625 U Taq DNA polymerase (Perkin-Elmer) in a
ﬁnal volume of 25 ml. ‘‘Hot’’ reactions also contained lyzed on an ABI 373 automated sequencer (Perkin-El-
mer). Sequence data was aligned using the Sequencher0.002 mCi a32P-dCTP (DuPont NEN). Reactions were
performed in the GeneAmp PCR System 9600 (Perkin- 3.0 software (Gene Codes). BLAST analysis (Altschul et
al. 1990) was performed using the NCBI Entrez BrowserElmer) with the following cycling conditions for exon
8: 5 min at 95C; 5 cycles of 10 s at 95C, 10 s at 65C (http://www3.ncbi.nlm.nih. gov/Entrez/). Protein align-
ment was performed using the ALIGN portion of theand 20 s at 72C; and 30 cycles at 10 s at 95C, 10 s at
60C, and 20 s at 72C. FASTA 2.0 program package (Pearson 1990) through
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the BCM search launcher (http://kiwi.imgen.bcm.t-
mc.edu:8088/).
Mutagenically Separated (MS) PCR
MS-PCR (Rust et al. 1993) genotyping was performed
using the following primers: Ex 8Mut (5-GCCCA
GCTTA TGCTA ACATT AGTAC CTCCC CCCTG
GGCAG GATTC A-3); Ex 8WT (5-TCTAC CTCCC
CCCTG GGCAG GAAAC G-3); and Ex 8B (5-
GGCAG ACAGC CGAAG GTCAG CAGTC-3). Engi-
neered mismatches are underlined. A 20-bp difference
in the lengths of primers Ex 8Mut and Ex 8WT results
in MS-PCR products of 145 bp and 125 bp for mutant
and wild-type genotypes, respectively. Reactions con-
tained 12.8 pg each of oligos Ex 8WT and Ex 8B and
6.4 pg of oligo Ex 8Mut. Conditions were otherwise Figure 2 MS-PCR genotyping of the G4.5 mutation in the
INVM family. A 100-bp ladder is shown at the left. The long primeridentical to those described above for exon ampliﬁca-
(Ex 8Mut) anneals to the mutant allele and results in a 145-bp producttion. MS-PCR products were run in 5% Nuseive 3:1
(lanes 3-5 and 7-8). The short primer (Ex 8WT) anneals to the wild-agarose for 2 h and were imaged as described.
type allele and results in a 125-bp product (lanes 1, 2, 4–7, 9, and
10).
Results
Linkage Analysis with INVM through the family (ﬁg. 2) and that it is not
present in 300 unrelated females (not shown).The apparent X-linked recessive inheritance of INVM
in this family was veriﬁed by linkage analysis. Initial
Blast Search and Alignmenthaplotyping for 12 STR markers spread across the X
While the function of the G4.5 gene products, knownchromosome at 15–20-cM intervals indicated cosegre-
as tafazzins, is unknown, a homologous C. elegans pro-gation of the INVM phenotype with the Xq28 region
tein called zk809.2 (Wilson et al. 1994)) was found in(data not shown). The family was then genotyped for
a BLAST search (Altschul et al. 1990) using the full-ﬁve STR markers mapping to the Xq28 region
length tafazzin protein. Bione et al (1996) noted two(DXS998, DXS1193, DXS52, F8C, and DXS1108)
regions of the G4.5 gene product that might be function-(Willard et al. 1994; Palmieri et al. 1994). Haplotype
ally signiﬁcant. Alignment of tafazzin and zk809.2 (ﬁg.analysis for these ﬁve markers (ﬁg. 1) showed complete
3) shows that the ﬁrst region, a 30-residue hydrophobicsegregation of INVM with the three most distal markers
N terminus, is mostly missing. The second region is a(DXS52, F8C, and DXS1108). Recombinational events
71-residue hydrophilic domain coded for by exons 5–were seen between INVM and markers DXS998 and
7. Residues corresponding precisely to exon 5, whichDXS1193, indicating that the defect in INVM lies distal
is frequently spliced out in humans, are missing fromto DXS1193 in a region corresponding to Ç6.8 Mb of
zk809.2. Strong conservation is seen (65% identity)DNA (Palmieri et al. 1994). The maximum LOD score
across the remaining hydrophilic domain, coded for bywas 3.64 at u Å 0 from DXS52.
exons 6 and 7 and the ﬁrst part of exon 8. Of this
conserved central domain, only the portion coded for inMutation Analysis
the ﬁrst part of exon 8 is common to all tafazzins. It is
Linkage localization to the Xq28 region and pheno-
in this invariable region where the Gly 197 Arg mutation
typic overlap with BTHS suggested that INVM in this
occurs (ﬁg. 3), further supporting the hypothesis that it
family might be caused by mutations in the G4.5 gene.
is responsible for INVM in this family.
PCR primers were designed to amplify all 11 exons of
G4.5 from genomic DNA of INVM patients and con-
Discussion
trols and were used to screen for mutations using SSCP
analysis. Ampliﬁcation products from exon 8 demon- Two transcription start sites and alternative splicing
of the G4.5 mRNA results in at least ﬁve different tran-strated a mobility shift in INVM patients versus con-
trols. Sequence analysis revealed a GrA transition muta- scripts, some with tissue-speciﬁc patterns of expression
(Bione et al. 1996). All BTHS mutations reported so fartion at nt 6 of exon 8 that results in a glycine-to-arginine
change at residue 197 of the G4.5 gene product. MS- have resulted in inactivation of several but not all tafaz-
zin proteins (Bione et al. 1996), either by introducingPCR was used to verify that the mutation segregated
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Figure 3 Alignment of the predicted full-length tafazzin protein and the C. elegans protein zk809.2. Identical residues are shaded.
Arrowheads and numbers indicate G4.5 exon boundaries. The exon 8, Gly 197rArg 197, mutation is labeled and boxed.
premature stop codons or by abolishing splice sites. We function information about tafazzin proteins. While this
mutation has a consistent and severe effect on the neona-report a nonconservative change in a domain common
to all tafazzin splice forms that results in a disorder with tal myocardium, effects on skeletal muscle and leuko-
cytes seem attenuated, even in the surviving transplantsevere and somewhat speciﬁc effects on the heart.
As yet, no function has been established for tafazzins. recipient. This suggests that the mutation effects a do-
main that is particularly important for cardiac muscleBione et al. (1996) noted that a central hydrophilic do-
main of the G4.5 gene product might be functionally function in the context of tissue speciﬁc expression of
various G4.5 splice forms. It is hoped that future studiessigniﬁcant, and we have found this domain to be highly
conserved in a putative C. elegans homologue. Thus, the of tafazzin expression and function will explain this spe-
ciﬁc effect.discovery of a nonconservative missense mutation in this
region, in an invariant part of the putative protein, could
be important in light of the severe cardiac phenotype it Acknowledgments
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